CL2007002621A1 - Bacterina tratada con calor donde las bacterias son de una a cinco especies de leptospira; una vacuna que comprende una emulsion y dicha bacterina; metodo para preparar dicha bacterina. - Google Patents

Bacterina tratada con calor donde las bacterias son de una a cinco especies de leptospira; una vacuna que comprende una emulsion y dicha bacterina; metodo para preparar dicha bacterina.

Info

Publication number
CL2007002621A1
CL2007002621A1 CL200702621A CL2007002621A CL2007002621A1 CL 2007002621 A1 CL2007002621 A1 CL 2007002621A1 CL 200702621 A CL200702621 A CL 200702621A CL 2007002621 A CL2007002621 A CL 2007002621A CL 2007002621 A1 CL2007002621 A1 CL 2007002621A1
Authority
CL
Chile
Prior art keywords
bacterine
leptospire
vaccine
bacteria
emulsion
Prior art date
Application number
CL200702621A
Other languages
English (en)
Inventor
Davis Goodyear Michael Jo Mark
Original Assignee
Pfizer Products Inc Sa Organiz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc Sa Organiz filed Critical Pfizer Products Inc Sa Organiz
Publication of CL2007002621A1 publication Critical patent/CL2007002621A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CL200702621A 2006-09-11 2007-09-10 Bacterina tratada con calor donde las bacterias son de una a cinco especies de leptospira; una vacuna que comprende una emulsion y dicha bacterina; metodo para preparar dicha bacterina. CL2007002621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11

Publications (1)

Publication Number Publication Date
CL2007002621A1 true CL2007002621A1 (es) 2008-03-14

Family

ID=39110574

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702621A CL2007002621A1 (es) 2006-09-11 2007-09-10 Bacterina tratada con calor donde las bacterias son de una a cinco especies de leptospira; una vacuna que comprende una emulsion y dicha bacterina; metodo para preparar dicha bacterina.

Country Status (27)

Country Link
US (1) US8491915B2 (es)
EP (2) EP2377550B1 (es)
JP (2) JP5550341B2 (es)
KR (1) KR101238486B1 (es)
CN (1) CN101516393B (es)
AR (1) AR062758A1 (es)
AU (1) AU2007297287B2 (es)
BR (1) BRPI0716548B1 (es)
CA (1) CA2663166C (es)
CL (1) CL2007002621A1 (es)
CO (1) CO6160333A2 (es)
DK (2) DK2066340T3 (es)
ES (2) ES2535977T3 (es)
HK (1) HK1130202A1 (es)
ME (1) MEP7509A (es)
MX (1) MX2009001849A (es)
NO (1) NO339147B1 (es)
NZ (2) NZ595748A (es)
PL (2) PL2066340T3 (es)
PT (1) PT2066340E (es)
RS (1) RS54981B1 (es)
RU (2) RU2425692C2 (es)
SI (1) SI2066340T1 (es)
TW (1) TWI361077B (es)
UA (1) UA98115C2 (es)
WO (1) WO2008032158A2 (es)
ZA (1) ZA200902493B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2224951T3 (da) * 2007-12-21 2020-01-06 Zoetis Services Llc Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
KR20230041660A (ko) * 2020-05-26 2023-03-24 사이러스 21 센추리 엔터프러너쉽 엘엘씨 하킴 포어 시나의 간드 조다-e

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
EP1549135A4 (en) 2002-09-20 2006-01-11 Us Agriculture VACCINE AND ADJUVANT COMPOSITIONS
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
JP2006515024A (ja) * 2003-01-29 2006-05-18 ファイザー・プロダクツ・インク Bordetellabronchisepticaに対するイヌワクチン
CN1767854B (zh) * 2003-04-04 2013-07-24 硕腾P有限责任公司 微流化水包油乳剂及疫苗组合物

Also Published As

Publication number Publication date
PL2066340T3 (pl) 2013-12-31
AU2007297287A1 (en) 2008-03-20
EP2377550A1 (en) 2011-10-19
WO2008032158A3 (en) 2008-07-03
UA98115C2 (ru) 2012-04-25
TWI361077B (en) 2012-04-01
EP2377550B1 (en) 2015-03-04
ES2432392T3 (es) 2013-12-03
EP2066340B1 (en) 2013-07-31
NZ574896A (en) 2011-11-25
CA2663166A1 (en) 2008-03-20
TW200820990A (en) 2008-05-16
CN101516393A (zh) 2009-08-26
AR062758A1 (es) 2008-12-03
RU2009108004A (ru) 2010-10-20
HK1130202A1 (en) 2009-12-24
RS20090088A (en) 2010-06-30
BRPI0716548A2 (pt) 2013-09-24
DK2066340T3 (da) 2013-10-14
ES2535977T3 (es) 2015-05-19
CA2663166C (en) 2015-11-03
AU2007297287B2 (en) 2013-03-14
CO6160333A2 (es) 2010-05-20
US8491915B2 (en) 2013-07-23
MX2009001849A (es) 2009-03-02
KR101238486B1 (ko) 2013-03-04
CN101516393B (zh) 2014-05-14
JP5643906B2 (ja) 2014-12-17
US20080112970A1 (en) 2008-05-15
SI2066340T1 (sl) 2013-11-29
KR20090039840A (ko) 2009-04-22
JP2014088428A (ja) 2014-05-15
WO2008032158A2 (en) 2008-03-20
EP2066340A2 (en) 2009-06-10
NO20090745L (no) 2009-03-11
ME00598B (me) 2011-12-20
PT2066340E (pt) 2013-10-30
BRPI0716548B1 (pt) 2020-10-06
MEP7509A (en) 2011-12-20
ZA200902493B (en) 2010-03-31
PL2377550T3 (pl) 2015-07-31
NO339147B1 (no) 2016-11-14
DK2377550T3 (en) 2015-04-07
NZ595748A (en) 2013-07-26
JP2010502238A (ja) 2010-01-28
JP5550341B2 (ja) 2014-07-16
RU2569457C2 (ru) 2015-11-27
RU2011115400A (ru) 2012-10-27
RS54981B1 (sr) 2016-11-30
RU2425692C2 (ru) 2011-08-10

Similar Documents

Publication Publication Date Title
BRPI1008076A2 (pt) sistema, método e aparelho para implementar implantes dentários
BRPI0807132A2 (pt) enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas
BRPI0922046A2 (pt) dispositivo de reprodução, método de reprodução e programa para reprodução estereoscópica
BRPI0719855A2 (pt) método para transferência de calor e dispositivo para tal.
BRPI0921228A2 (pt) sistema de distribuição de potência e método do mesmo.
BRPI0916472A2 (pt) dispositivo de tratamento de ferimento, método para tratamento de um ferimento e dispositivo de tratamento de ferimento
BRPI0718860A2 (pt) composição virucida e método para matar vírus
BRPI0815283A2 (pt) Equipamento para o tratamento da biomassa, método para o tratamento da biomassa, biomassa tratada e hidrolisado
BRPI0920283A2 (pt) composição e método para induzir resposta imunológica humoral
BRPI0920282A2 (pt) composição e método para induzir resposta imunológica humoral
BRPI0918647A2 (pt) sistema automatizado de plantio experimental de sementes, método de plantio de uma parcela experimental e aparelho automatizado para o plantio experimental de sementes
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
BRPI0923315A2 (pt) método sistema e utilização para comutação de calor.
BRPI0820341A2 (pt) bactéria mycoplasma viva, atenuada, composição de vacina e métodod para identificar clones de mycoplasma atenuados
BRPI1016094A2 (pt) "métodos para tratar uma mistura de lipídio inicial, para processar lipídios e para manipular lipídios"
BR112013015717A2 (pt) dispositivo de inserção vaginal, aparelho, kit e método para fabricação do dispositivo de inserção vaginal
BRPI0912733A2 (pt) sistema e método para processamento de alimento
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
FI20085409A0 (fi) Menetelmä ja laite viestien käsittelemiseksi
BR112012004141A2 (pt) método e kit para recuperar antígenos em uma amostra de tecido fixada em formaldeído, e, dispositivo de manipulação de amostra
CL2014001719A1 (es) Metodo para tratar la perdida osea alveolar que comprende anticuerpo antiesclerostina.
EP2979651A4 (en) ENDOSCOPE SURGICAL DEVICE, AND ENDOSCOPE INSERTION / REMOVAL METHOD, AND TREATMENT INSTRUMENT
BR112015008630A2 (pt) método para uso do calor de escape em uma instalação para produção de cimento e instalação para produção de cimento.
BRPI0819938A2 (pt) Vacinas com bactérias e com emulsão tratadas com calor preparadas a partir de tais bactérias tratadas com calor
BRPI0924398A2 (pt) perexilina, metodo de tratamento de hfnef e programa de tratamento para tratar hfnef